Cancer immunotherapy has the potential to revolutionize the treatment of malignant tumors,
but its effectiveness is limited by the low immune response rate and immune‐related …

Yang et al. recently demonstrated the high potential of liquid metal microspheres (LM MSs)
in cancer therapy. By amplifying the effects of magnetic hyperthermia and embolization, LM …

Nanomedicine application in cancer therapy is an urgency because of inability of current
biological therapies for complete removal of tumor cells. The development of smart and …

Pyroptosis is a lytic and inflammatory type of programmed cell death that is mediated by
Gasdermin proteins (GSDMs). Attractively, recent evidence indicates that pyroptosis involves …

The development of targeted drug delivery systems (DDSs) has revolutionized cancer
therapy by improving the selectivity of drug delivery to cancer cells, thereby reducing …

Doxorubicin (Dox) is a highly potent chemotherapy drug. Despite its efficacy, Dox's clinical
application is limited due to its association with significant complications, namely …

Doxorubicin (DOX), a commonly used anti-cancer drug, is limited by its cardiotoxicity and
multidrug resistance (MDR) of tumor cells. Epigallocatechin gallate (EGCG), a natural …

Implantable medical devices have played an important role in human medicine in recent
decades. However, traditional implanted devices require battery replacement and a second …

Tumors compromise T cell functionality through various mechanisms, including the induction
of a nutrient-scarce microenvironment, leading to lipid accumulation and metabolic …

Highly immunogenic programmed death of tumor cells, such as immunogenic cell death
(ICD) and pyroptosis, strengthens antitumor responses and thus represents a promising …